Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients

NCT02944214 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
Hyperuricemia
Abnormal Renal Function

Interventions

DRUG: Febuxostat
DRUG: Benzbromarone

Sponsor

Shanghai 10th People's Hospital